These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 405394)

  • 1. Inosine uptake by cultured fibroblasts from normal and purine nucleoside phosphorylase-deficient humans.
    Cohen A; Martin DW
    J Biol Chem; 1977 Jun; 252(12):4428-30. PubMed ID: 405394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purine metabolism in intact cells from a purine nucleoside phosphorylase deficient child.
    Cohen A; Barankiewicz J; Issekutz A; Gelfand EW
    Adv Exp Med Biol; 1984; 165 Pt B():163-6. PubMed ID: 6426262
    [No Abstract]   [Full Text] [Related]  

  • 3. Inosine formation from hypoxanthine by intact erythrocytes and fibroblasts of an immunodeficient child with purine nucleoside phosphorylase deficiency.
    Fairbanks LD; Webster DR; Simmonds HA; Potter CF; Watson AR
    Adv Exp Med Biol; 1984; 165 Pt B():167-70. PubMed ID: 6426263
    [No Abstract]   [Full Text] [Related]  

  • 4. Purine metabolism in cultured human fibroblasts derived from patients deficient in hypoxanthine phosphoribosyltransferase, purine nucleoside phosphorylase, or adenosine deaminase.
    Thompson LF; Willis RC; Stoop JW; Seegmiller JE
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3722-6. PubMed ID: 99741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of purine nucleosides in cultured fibroblasts from a patient with purine nucleoside phosphorylase deficiency and associated T-cell immunodeficiency.
    Burke WG; Chen SH; Scott CR; Ammann AJ
    J Cell Physiol; 1977 Jul; 92(1):109-13. PubMed ID: 408357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A patient with purine nucleoside phosphorylase deficiency: enzymological and metabolic aspects.
    Siegenbeek Van Heukelom LH; Akkerman JW; Staal GE; De Bruyn CH; Stoop JW; Zegers BJ; De Bree PK; Wadman SK
    Clin Chim Acta; 1977 Feb; 74(3):271-9. PubMed ID: 401697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposed explanation for S-adenosylhomocysteine hydrolase deficiency in purine nucleoside phosphorylase and hypoxanthine-guanine phosphoribosyltransferase-deficient patients.
    Hershfield MS
    J Clin Invest; 1981 Mar; 67(3):696-701. PubMed ID: 6782120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purine nucleoside phosphorylase deficiency: altered kinetic properties of a mutant enzyme.
    Fox IH; Andres CM; Gelfand EW; Biggar D
    Science; 1977 Sep; 197(4308):1084-6. PubMed ID: 407651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase.
    Cohen A; Doyle D; Martin DW; Ammann AJ
    N Engl J Med; 1976 Dec; 295(26):1449-54. PubMed ID: 825775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitated transport of inosine and uridine in cultured mammalian cells is independent of nucleoside phosphorylases.
    Plagemann PG; Wohlhueter RM; Erbe J
    Biochim Biophys Acta; 1981 Jan; 640(2):448-62. PubMed ID: 6783140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transport of adenine, hypoxanthine and uracil into Escherichia coli.
    Burton K
    Biochem J; 1977 Nov; 168(2):195-204. PubMed ID: 413544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial deficiency of purine nucleoside phosphorylase: studies of purine and pyrimidine metabolism.
    Edwards NL; Gelfand EW; Biggar D; Fox IH
    J Lab Clin Med; 1978 May; 91(5):736-49. PubMed ID: 417142
    [No Abstract]   [Full Text] [Related]  

  • 13. Altered purine and pyrimidine metabolism in erythrocytes with purine nucleoside phosphorylase deficiency.
    Fox IH; Kaminska J; Edwards NL; Gelfand E; Rich KC; Arnold WN
    Biochem Genet; 1980 Apr; 18(3-4):221-34. PubMed ID: 6160848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deoxyguanosine toxicity on lymphoid cells as a cause for immunosuppression in purine nucleoside phosphorylase deficiency.
    Chan TS
    Cell; 1978 Jul; 14(3):523-30. PubMed ID: 99242
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of a cell culture model for the study of adenosine deaminase- and purine nucleoside phosphorylase-deficient immunologic disease.
    Ullman B; Cohen A; Martin DW
    Cell; 1976 Oct; 9(2):205-11. PubMed ID: 184961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for active purine nucleoside cycles in human mononuclear cells and cultured fibroblasts.
    Barankiewicz J; Gelfand EW; Issekutz A; Cohen A
    J Biol Chem; 1982 Oct; 257(19):11597-600. PubMed ID: 6811584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of TEI-6720, a xanthine oxidase inhibitor, on the nucleoside transport in the lung cancer cell line A549.
    Yamamoto T; Moriwaki Y; Fujimura Y; Takahashi S; Tsutsumi Z; Tsutsui T; Higashino K; Hada T
    Pharmacology; 2000 Jan; 60(1):34-40. PubMed ID: 10629441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The existance of a group translocation transport mechanism in animal cells: uptake of the ribose moiety of inosine.
    Quinlan DC; Li CC; Hochstadt J
    J Supramol Struct; 1976; 4(4):387-99. PubMed ID: 180353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hexamere purine nucleoside phosphorylase from Escherichia coli K-12. Kinetic analysis and mechanism of reaction].
    Bezirdzhian KhO; Kocharian ShM; Akopian ZhI
    Biokhimiia; 1987 Nov; 52(11):1770-6. PubMed ID: 3125860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of 5-methyluridine by immobilized thermostable purine nucleoside phosphorylase and pyrimidine nucleoside phosphorylase from Bacillus stearothermophilus JTS 859.
    Hori N; Watanabe M; Sunagawa K; Uehara K; Mikami Y
    J Biotechnol; 1991 Feb; 17(2):121-31. PubMed ID: 1367490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.